The product is disappearing into reorder rhythm: revenue is shifting from won-each-time to arriving-on-its-own, and the
The model's full reasoning — Q4 2023 call → NOWe need answer only YES or NO. Need analyze transcript. Question asks: Does management describe that a growing share of company's revenue now arrives without a new selling event — through reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket or consumable pull-through, or customers' own standing routines — AND that this self-arriving share has recently and visibly grown as a proportion of business, with management grounding shift in observed current behavior and treating it as changing quality of revenue? Need use only transcript. Need identify if management describes such. Company is Palatin, Vyleesi product. They discuss Vyleesi gross product sales, net product revenue, prescriptions dispensed, refill rates. They mention "refill rates, commercial insurance reimbursement and net revenue per prescription dispensed continued with impactful results and trends versus prior quarter and comparable quarter last year." Also "All the value metrics are moving in a positive direction. Refill rates, commercial insurance reimbursement and net revenue per prescription dispensed continued with impactful results and trends versus the prior quarter and comparable quarter last year." Also "six consecutive quarters of double-digit growth" and "net product revenue increased 47% and prescription dispensed increased 16% over prior quarter." They mention "Vyleesi quarterly net product revenue continues to exceed Vyleesi quarterly operating expenses, i.e., we make some money." But do they explicitly describe that a growing share of revenue arrives without a new selling event through refills/reorders? They mention refill rates as a metric, but not necessarily that revenue is self-arriving or that proportion has grown. Need see if they describe "refill rates" as observed current behavior and that it's growing as proportion. They say "Refill rates, commercial insurance reimbursement and net revenue per prescription dispensed continued with impactful results and trends versus the prior quarter and comparable quarter last year." That suggests refill rates are improving. But is that "self-arriving revenue" as a share? Refills are repeat purchases by patients. They are part of revenue. Management mentions refill rates as positive.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
DUOT · Q4 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, through reorders, renewals, etc., and that this has recently and visibly grown as a ...
QTRX · Q3 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through reorders, consumables, etc., and that this share has recently grown.
CYBR · Q3 2021 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through renewals, and that this has recently grown as a proportion.